TNF-Related Apoptosis-Inducing Ligand (TRAIL) as a Pro-Apoptotic Signal Transducer with Cancer Therapeutic Potential

E-ISSN： 1873-4286|11|7|933-944

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.7, 2005-03, pp. : 933-944

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of TNF-related apoptosis-inducing ligand receptor antibodies

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 7, 2003-07 ,pp. : 1081-1086

Informa Healthcare

Access to resources Recommend Favorite

TNF-Related Apoptosis-Inducing Ligand (TRAIL): A Potential Candidate for Combined Treatment of Hematological Malignancies

Current Pharmaceutical Design, Vol. 10, Iss. 29, 2004-11 ,pp. : 3673-3681

Bentham Science Publishers

Access to resources Recommend Favorite

Doxorubicin Sensitizes the Non-Small Cell Lung Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated (TRAIL) Apoptosis In Vitro but not In Vivo

Letters in Drug Design & Discovery, Vol. 8, Iss. 9, 2011-11 ,pp. : 861-867

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines

By Sonnemann Jürgen Gänge Jennifer Kumar K. Müller Cornelia Bader Peter Beck James

Investigational New Drugs, Vol. 23, Iss. 2, 2005-01 ,pp. : 99-109

Springer Publishing Company

Access to resources Recommend Favorite

The Development of Pro-Apoptotic Cancer Therapeutics

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-06 ,pp. : 711-718

Bentham Science Publishers

Access to resources Recommend Favorite